lomustine has been researched along with Anal Cancer in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metastatic anal cancer is a rare disease in the Western hemisphere and current treatment modalities are not effective." | 2.72 | Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282. ( Catalano, PJ; Hahn, RG; Haller, D; Harris, J; Jhawer, M; Lefkopoulou, M; Mani, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jhawer, M | 1 |
| Mani, S | 1 |
| Lefkopoulou, M | 1 |
| Hahn, RG | 1 |
| Harris, J | 1 |
| Catalano, PJ | 1 |
| Haller, D | 1 |
1 trial available for lomustine and Anal Cancer
| Article | Year |
|---|---|
Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bleomycin; Ci | 2006 |